Centessa Pharmaceuticals plc American Depositary Shares (CNTA)
PHARMACEUTICAL PREPARATIONS
Centessa Pharmaceuticals plc American Depositary Shares (CNTA) was listed on Nasdaq from May 28, 2021 and stopped trading under the symbol CNTA on June 25, 2026.
- Listed On
- Nasdaq
- Listed Since
- May 28, 2021
- Stopped Trading
- June 25, 2026
- Employees
- 129
About Centessa Pharmaceuticals plc American Depositary Shares
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1 institution reported holding CNTA, with 0 shares worth $0 in aggregate. The largest reported holder was Janus Henderson (Jupiter Topco). Of the 1 largest holders listed below, 1 sold out during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Janus Henderson (Jupiter Topco) | Sold out |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is CNTA?
Centessa Pharmaceuticals plc American Depositary Shares (CNTA) was listed on Nasdaq from May 28, 2021 and stopped trading under the symbol CNTA on June 25, 2026.
Who are the largest institutional holders of CNTA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CNTA were Janus Henderson (Jupiter Topco).
How many institutions own CNTA?
1 institution reported a position in CNTA for the quarter ended June 30, 2026, worth $0 in total.
Did institutions buy or sell CNTA last quarter?
Of the 1 largest reported holders, 1 sold out during the quarter. Every reported holder and its change is on the SentiSense ownership page for CNTA.
Every reported institutional holder, plus insider and congressional trades in CNTA, on SentiSense.